Kezar Life Sciences, Inc. (KZR) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -7.45M | -11.96M | -9.83M | -12.79M | -17.19M | -16.82M | -17.49M | -17.03M | -22.86M | -18.98M | -20.2M | -21.6M | -20.86M | -15.88M | -16.36M | -13.29M | -13.31M | -11.08M | -9.95M | -13.04M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | -288.64% | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 56.69% | 28.9% | 43.81% | 24.87% | 24.81% | 11.35% | 13.42% | 21.15% | -9.6% | -19.5% | -23.5% | -62.54% | -56.68% | -43.34% | -64.36% | -1.87% | -59.32% | -19.06% | -7.61% | -29.27% |
| Net Income | -5.76M | -14.55M | -11.23M | -13.7M | -16.56M | -20.22M | -20.31M | -21.55M | -21.66M | -32.26M | -23.1M | -24.31M | -22.2M | -18.18M | -17.85M | -16.19M | -16.02M | -14.21M | -14.46M | -12.96M |
| Depreciation & Amortization | 47K | 631K | 227K | -344K | 251K | 259K | -3.87M | 261K | 260K | 280K | 278K | 249K | 259K | -283K | 458K | 431K | 417K | 387K | 378K | 373K |
| Stock-Based Compensation | 653K | 1.63M | 2.14M | 2.42M | 2.78M | 3.31M | 3.19M | 3.08M | 3.43M | 3.22M | 6.63M | 4.02M | 4.26M | 3.82M | 3.79M | 3.3M | 3.1M | 1.85M | 1.88M | 1.94M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.76M | -1.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.39M | 597K | -179K | 42K | -529K | -841K | 998K | 225K | -1.45M | 1.44M | 58K | 59K | -1.65M | -1.29M | -572K | 297K | 392K | 408K | 408K | 531K |
| Working Capital Changes | 0 | -271K | -787K | -1.21M | -3.13M | 668K | 2.5M | 945K | -3.45M | 8.35M | -2.31M | 199K | -1.53M | 58K | -2.19M | -1.13M | -1.2M | 483K | 1.84M | -2.92M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.84M | -590K | -426K | -2.73M | -3.6M | -1.54M | 1.5M | -97K | -3.01M | 0 | 2.94M | 1.1M | 1.35M | 2.37M | 2.17M | 0 | -834K | 60K | 1.73M | -1.66M |
| Cash from Investing | 1.53M | 51.61M | 15.71M | 11.4M | 13.74M | 23.74M | 24.06M | 12.22M | 20.41M | 27.88M | 18.57M | 13.2M | 16.39M | -8.66M | -24.71M | 1.51M | -59.53M | -82.49M | 38.48M | 16.25M |
| Capital Expenditures | 0 | 0 | 0 | 0 | -8K | -11K | -18K | 0 | 0 | -1K | -136K | -1.38M | -297K | -343K | -603K | -182K | -450K | -266K | -26K | -24K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | 1.94% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 112K | 9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | -14.58K | -16.69K | 8.32K | 24.11K | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 1.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14.58K | 16.69K | -8.32K | -24.11K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 267K | -6.71M | -1.3M | -1.27M | -1.3M | 47K | 0 | 56K | 0 | 59K | 43K | 382K | 154K | 506K | 185K | 78.32M | 48.85M | 99.36M | 2.21M | 282K |
| Debt Issued (Net) | 0 | -6.74M | -1.3M | -1.3M | -1.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.53M | 0 | 0 |
| Equity Issued (Net) | 0 | 30K | 0 | 35K | 0 | -56K | 0 | 56K | 0 | -579K | 43K | 382K | 154K | -813K | 185K | 78.32M | 48.85M | 89.83M | 2.21M | 282K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 267K | 0 | 0 | 0 | 0 | 103K | 0 | 0 | 0 | 638K | 0 | 0 | 0 | 1.32M | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -5.65M | 32.94M | 4.57M | -2.63M | -4.75M | 6.89M | 6.58M | -4.76M | -2.46M | 8.99M | -1.61M | -8.02M | -4.33M | -24M | -40.93M | 66.48M | -23.97M | 5.79M | 30.71M | 3.47M |
| Free Cash Flow | -7.45M | -11.96M | -9.83M | -12.79M | -17.2M | -16.84M | -17.51M | -17.03M | -22.86M | -18.98M | -20.34M | -22.98M | -21.16M | -16.23M | -16.96M | -13.47M | -13.76M | -11.35M | -9.98M | -13.07M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | -290.59% | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 56.71% | 28.95% | 43.87% | 24.87% | 24.77% | 11.3% | 13.91% | 25.87% | -8.06% | -16.98% | -19.91% | -70.56% | -53.71% | -43% | -69.97% | -3.08% | -64.7% | -20.83% | -7.89% | -29.29% |
| FCF per Share | -1.01 | -1.63 | -1.34 | -1.75 | -2.35 | -2.31 | -0.24 | -0.23 | -0.31 | -0.26 | -0.28 | -0.32 | -0.29 | -0.22 | -0.24 | -0.21 | -0.23 | -0.20 | -0.19 | -0.25 |
| FCF Conversion (FCF/Net Income) | 1.29x | 0.82x | 0.88x | 0.93x | 1.04x | 0.83x | 0.86x | 0.79x | 1.06x | 0.59x | 0.87x | 0.89x | 0.94x | 0.87x | 0.92x | 0.82x | 0.83x | 0.78x | 0.69x | 1.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 324K | 0 | 0 | 0 | 340K | 0 | 0 | 0 | 0 | 0 | 18K | 201K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |